col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: International Journal of Biological Macromolecules
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―10 Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation Nemat Ali, Kartikay Prasad, Abdullah F. AlAsmari, Metab Alharbi, Summya Rashid, Vijay Kumar
2 [GO] 2021―Sep―07 Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2 Letian Li, Maopeng Wang, Jiayi Hao, Jicheng Han, Tingting Fu, Jieying Bai, et al. (+4)
3 [GO] 2021―Aug―18 Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach Mehrnaz Ebrahimi, Parviz Norouzi, Hossein Aazami, Ali Akbar Moosavi-Movahedi
4 [GO] 2021―Aug―14 SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, et al. (+3)
5 [GO] 2021―Aug―06 Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease Yunxia Xu, Ke Chen, Juanli Pan, Yingshou Lei, Danting Zhang, Lipei Fang, et al. (+8)
6 [GO] 2021―Aug―06 The method utilized to purify the SARS-CoV-2 N protein can affect its molecular properties Aneta Tarczewska, Marta Kolonko-Adamska, Mirosław Zarębski, Jurek Dobrucki, Andrzej Ożyhar, Beata Greb-Markiewicz
7 [GO] 2021―Jul―30 Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms Yuan Xiong, Guang-Hao Zhu, Ya-Ni Zhang, Qing Hu, Hao-Nan Wang, Hao-Nan Yu, et al. (+5)
8 [GO] 2021―Jul―27 Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus Chandrima Modak, Anubhuti Jha, Nivya Sharma, Awanish Kumar
9 [GO] 2021―Jul―05 Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2 Pravas Kumar Baral, Jiang Yin, Michael N.G. James
10 [GO] 2021―Jun―07 A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2) Mao-Sen Zeng, Wen-Di Yu, Hui-Xian Wang, Jin-Yuan Liu, Pei-Ping Xu
11 [GO] 2021―May―26 Ethyl cellulose coated sustained release aspirin spherules for treating COVID-19: DOE led rapid optimization using arbitrary interface; applicable for emergency situations T. Sreejith, Kaladhar Kamalasanan, Ashna Moidu, Pooja Shyamsundar, Shanti V. Nair, Lakshmi J. Nair, P. Venkatesan
12 [GO] 2021―May―25 Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain
13 [GO] 2021―Apr―27 Chitin and chitosan as tools to combat COVID-19: A triple approach Mehrnoush Safarzadeh, Sahar Sadeghi, Mahdieh Azizi, Mohsen Rastegari-Pouyani, Ramin Pouriran, Mostafa Haji Molla Hoseini
14 [GO] 2021―Apr―26 Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy Yash Gupta, Dawid Maciorowski, Samantha E. Zak, Chandrashekhar V. Kulkarni, Andrew S. Herbert, Ravi Durvasula, et al. (+3)
15 [GO] 2021―Apr―24 Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro Ruyu Wang, Qing Hu, Haonan Wang, Guanghao Zhu, Mengge Wang, Qian Zhang, et al. (+6)
16 [GO] 2021―Apr―21 Preparation of cellulose based wipes treated with antimicrobial and antiviral silver nanoparticles as novel effective high-performance coronavirus fighter Tamer Hamouda, Hassan M. Ibrahim, H.H. Kafafy, H.M. Mashaly, Nasser H. Mohamed, Nermin M. Aly
17 [GO] 2021―Apr―16 Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Vladimir N. Uversky, Alaa A.A. Aljabali, et al. (+19)
18 [GO] 2021―Mar―29 A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients Ipsita Kumar Sen, Indranil Chakraborty, Amit Kumar Mandal, Sunil Kumar Bhanja, Sukesh Patra, Prasenjit Maity
19 [GO] 2021―Mar―23 A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase Suliman Khan, Farnoosh Attar, Samir Haj Bloukh, Majid Sharifi, Faisal Nabi, Qian Bai, et al. (+2)
20 [GO] 2021―Mar―12 Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic Nairah Noor, Adil Gani, Asir Gani, Asima Shah, Zanoor ul Ashraf
21 [GO] 2021―Mar―02 The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, et al. (+3)
22 [GO] 2021―Mar―01 SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development Mandeep Kaur, Akanksha Sharma, Santosh Kumar, Gurpal Singh, Ravi P. Barnwal
23 [GO] 2021―Feb―17 Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2? Nivya Sharma, Chandrima Modak, Pankaj Kumar Singh, Rahul Kumar, Dharmender Khatri, Shashi Bala Singh
24 [GO] 2021―Feb―11 COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study Shima Parsa, Vahid Mogharab, Mohsen Ebrahimi, Sayyed Reza Ahmadi, Behzad Shahi, Neema John Mehramiz, et al. (+7)
25 [GO] 2021―Feb―09 Potential drug targets of SARS-CoV-2: From genomics to therapeutics Anas Shamsi, Taj Mohammad, Saleha Anwar, Samreen Amani, Mohd Shahnawaz Khan, Fohad Mabood Husain, et al. (+3)
26 [GO] 2021―Feb―05 Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 Ashuai Du, Rong Zheng, Cyrollah Disoma, Shiqin Li, Zongpeng Chen, Sijia Li, et al. (+18)
27 [GO] 2021―Feb―05 Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein Shruti Mukherjee, Amaravadhi Harikishore, Anirban Bhunia
28 [GO] 2021―Jan―11 SARS-Cov-2 ORF3a: Mutability and function Martina Bianchi, Alessandra Borsetti, Massimo Ciccozzi, Stefano Pascarella
29 [GO] 2020―Dec―29 Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study Shreya Bhattacharya, Arundhati Banerjee, Sujay Ray
30 [GO] 2020―Dec―09 Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs Naveen Narayanan, Deepak T. Nair
31 [GO] 2020―Dec―06 Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches Vinit Raj, Jae Gyu Park, Kiu-Hyung Cho, Pilju Choi, Taejung Kim, Jungyeob Ham, Jintae Lee
32 [GO] 2020―Sep―28 Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials Fatemeh Oroojalian, Ali Haghbin, Behzad Baradaran, Nima Hemmat, Mohammad-Ali Shahbazi, Hossein Bannazadeh Baghi, et al. (+2)
33 [GO] 2020―Sep―24 Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13) Osman Mutluhan Ugurel, Ozal Mutlu, Emrah Sariyer, Sinem Kocer, Erennur Ugurel, Tugba Gul Inci, et al. (+2)
34 [GO] 2020―Sep―24 The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica Weihua Jin, Wenjing Zhang, Dipanwita Mitra, Martin G. McCandless, Poonam Sharma, Ritesh Tandon, et al. (+2)
35 [GO] 2020―Sep―17 Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach Md. Sorwer Alam Parvez, Md. Adnan Karim, Mahmudul Hasan, Jomana Jaman, Ziaul Karim, Tohura Tahsin, et al. (+2)
36 [GO] 2020―Aug―24 Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2 Praveen Kumar Tripathi, Saurabh Upadhyay, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Pradeep Sharma, Ashok Kumar Patel
37 [GO] 2020―Aug―01 Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening Olga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T. Reyburn, et al. (+2)
38 [GO] 2020―Jul―18 A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor Pedro F.N. Souza, Francisco E.S. Lopes, Jackson L. Amaral, Cleverson D.T. Freitas, Jose T.A. Oliveira
39 [GO] 2020―Jul―15 Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach Samira Sanami, Milad Zandi, Behzad Pourhossein, Gholam-Reza Mobini, Mohsen Safaei, Atena Abed, et al. (+3)
40 [GO] 2020―Jul―14 Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines Xiangyan Chen, Wenwei Han, Guixiang Wang, Xia Zhao
41 [GO] 2020―Jun―26 Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective Kartikay Prasad, Fatima Khatoon, Summya Rashid, Nemat Ali, Abdullah F. AlAsmari, Mohammad Z. Ahmed, et al. (+3)
42 [GO] 2020―Jun―26 Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach Ishtiaque Ahammad, Samia Sultana Lira
43 [GO] 2020―May―30 A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2 Maopeng Wang, Tingting Fu, Jiayi Hao, Letian Li, Mingyao Tian, Ningyi Jin, et al. (+2)
44 [GO] 2020―May―26 High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment Biswajit Naik, Nidhi Gupta, Rupal Ojha, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty
45 [GO] 2019―Dec―02 Construction and optimization of Lactobacillus plantarum expression system expressing glycoprotein 5 of porcine reproductive and respiratory syndrome virus Maopeng Wang, Shouwen Du, Wang Xu, Lina Song, Pengfei Hao, Ningyi Jin, et al. (+2)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.011 sec